| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.6M | — | — |
| R&D Expense | $95.7M | +10.5% | +35.0% |
| SG&A Expense | $19.4M | — | +43.5% |
| Operating Income | -$108.5M | — | -28.6% |
| Income Tax | $0 | — | — |
| Net Income | -$98.5M | — | -36.5% |
| EPS (Basic) | -$1.11 | — | -35.4% |
| EPS (Diluted) | -$1.11 | — | -35.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $157.5M | +39.6% | +21.2% |
| Short-term Investments | $513.7M | -2.4% | -8.7% |
| Current Assets | $696.1M | +4.4% | -1.7% |
| Total Assets | $1.03B | -7.1% | -6.4% |
| Current Liabilities | $64.8M | +10.2% | +27.5% |
| Total Liabilities | $93.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$75.2M | — | -24.6% |
| Capital Expenditures | $967K | — | -27.3% |
| Investing Cash Flow | $119.0M | — | +49.0% |
| Financing Cash Flow | $1.2M | — | -95.5% |
| Free Cash Flow | -$76.1M | — | -23.5% |
| +21.7% |
| Stockholders' Equity | $937.3M | -8.4% | -8.5% |